Palladium Dendrimers Copolymerizing CO/Styrene
Organometallics, Vol. 25, No. 12, 2006 3053
1
follows. H NMR (CDCl3): δ 0.28 (s, 9H, SiMe3), 0.84 (s, 3H,
(40 mL), and the resulting yellow suspension was stirred at room
temperature for 48 h. Removal of the solvent, followed by washings
of the residue with pentane (4 × 5 mL), gave compound 4a as a
yellow solid, soluble in DMSO and insoluble in alkanes and
aromatic and chlorinated solvents. Yield: 300 mg (89%). Anal.
Calcd for C68H84N8O4Si5Cl8Pd4 (1927.20): C, 42.38; H, 4.39; N,
5.81. Found: C, 42.05; H, 4.57; N, 5.25. 1H NMR (DMSO-d6): δ
0.22 (s, 6H, SiMe2), 0.60 (m, 2H, SiCH2), 0.81 (m, 2H, CH2SiMe2),
1.39 (m, 2H, CH2CH2CH2), 6.81 (AA′ part of an AA′BB′ spin
system, 2H, H3,5), 7.34 (BB′ part of an AA′BB′ spin system, 2H,
H2,6), 7.88 (m, 1H, H11), 8.16 (m, 1H, H9), 8.35 (m, 1H, H10), 8.66
(s, 1H, H7), 8.98 (m 1H, H12). 13C{1H} NMR (DMSO-d6): δ -1.8
(SiMe2), 15.9 (CH2), 16.9 (CH2), 20.2 (CH2), 118.4 (C3,5), 125.2
(C2,6), 128.1 (C9), 128.8 (C11), 140.4 (C1), 140.7 (C10), 149.4 (C12),
154.7 (C4), 155.3 (C8), 170.9 (C7). IR (KBr): ν 1615 (vw), 1595-1
(s, CdN).
PdMe), 2.30 (s, 3H, CH3CN), 6.84 (AA′ part of an AA′BB′ spin
system, 2H, H3,5), 7.13 (BB′ part of an AA′BB′ spin system, 2H,
H2,6), 7.42 (pt, 1H, H11), 7.49 (broad s, 4H, Arf Hp), 7.68 (broad s,
9H, H9 and Arf Ho overlapping), 7.88 (pt, 1H, H10), 8.22 (s, 1H,
H7), 8.31 (d, 1H, JH,H ) 5.1 Hz, H12). 19F{1H} NMR (CDCl3): δ
-106.3 (s, CF3). IR (KBr): ν 1610 cm-1 (m, CdN). MS (ESI+ in
CH3CN): m/z 432 [M - BArf4]+, 270 [Ia]+. MS (ESI- in CH3-
CN): m/z 863 [BArf4]-.
[PdMe(MeCN)(Ib)]+[BArf4]- (3b). Orange-yellow solid. Mix-
ture of 44% cis and 56% trans isomers. Yield: 69%. Anal. Calcd
for C52H40N3OSiPdBF24 (1324.19): C, 47.17; H, 3.04; N, 3.17.
Found: C, 46.80; H, 2.94; N, 3.17. NMR data for the major isomer
1
are as follows. H NMR (CDCl3): δ 0.27 (s, 9H, SiMe3), 1.08 (s,
3H, PdMe), 2.04 (s, 3H, Me14), 2.15 (s, 3H, CH3CN), 2.31 (s, 3H,
Me13), 6.66 (s, 1H, H3), 6.74 (s, 1H, H6), 7.49 (broad s, 4H, Arf
Hp), 7.58 (pt, 1H, H11), 7.68 (broad s, 9H, H9 and Arf Ho
overlapping), 8.00 (pt, 1H, H10), 8.20 (s, 1H, H7), 8.42 (d, 1H, JH,H
) 5.0 Hz, H12). 13C{1H} NMR (CDCl3): δ 0.6 (SiMe3), 2.9 (PdMe),
4.6 (CH3CN), 16.3 and 18.2 (Me13,14), 117.3 (Arf Cp), 120.9 (C3),
123.0 (C6), 124.3 (q, JC,F ) 271.7 Hz, CF3), (C2 and C5 not
assigned), 128.3 (C9), 128.5 (C11), 128.7 (q, JC,F ) 28.1 Hz, Arf
Cm), 134.5 (Arf Co), 139.7 (C1), 140.4 (C10), 149.2 (C12), 154.1
(C8), 155.3 (C4), 161.3 (q, JC,B ) 49.6 Hz, Arf Cipso), 161.4 (C7).
NMR data for the minor isomer are as follows. 1H NMR (CDCl3):
δ 0.28 (s, 9H, SiMe3), 0.72 (s, 3H, PdMe), 2.14 (s, 3H, Me14),
2.17 (s, 3H, Me13), 2.30 (s, 3H, CH3CN), 6.64 (s, 1H, H3), 6.69 (s,
1H, H6), 7.40 (pt, 1H, H11), 7.49 (broad s, 4H, Arf Hp), 7.68 (broad
s, 9H, H9 and Arf Hp overlapping), 7.85 (pt, 1H, H10), 8.27 (s, 1H,
H7), 8.31 (d, 1H, JH,H ) 5.0 Hz, H12). 13C{1H} NMR (CDCl3): δ
0.7 (SiMe3), 3.3 (PdMe), 6.4 (CH3CN), 16.4 and 17.8 (Me13,14),
117.3 (Arf Cp), 120.8 (C3), 123.5 (C6), 124.3 (q, JC,F ) 271.7 Hz,
CF3), (C1, C2, and C5 not assigned), 127.7 (C9), 129.4 (C11), 128.7
(q, JC,F ) 28.1 Hz, Arf Cm), 134.5 (Arf Co), 140.0 (C10), 148.6 (C12),
150.2 (C8), 153.6 (C4), 161.3 (q, JC,B ) 49.6 Hz, Arf Cipso), 169.9
(C7). 19F{1H} NMR (CDCl3): δ -106.3 (s, CF3). IR (KBr): ν 1611
cm-1 (m, CdN). MS (ESI+ in CH3CN): m/z 460 [M - BArf4]+,
298 [Ib]+. MS (ESI- in CH3CN): m/z 863 [BArf4]-.
G1-ONNMe2[PdCl2] (4b). Orange solid slightly soluble in polar
solvents and insoluble in alkanes and halogenated solvents. Yield:
80%. Anal. Calcd for C76H100N8O4Si5Cl8Pd4 (2039.41): C, 44.76;
1
H, 4.94; N, 5.49. Found: C, 45.57; H, 5.44; N, 5.19. H NMR
(DMSO-d6): δ 0.21 (s, 6H, SiMe2), 0.63 (m, 2H, SiCH2), 0.81 (m,
2H, CH2SiMe2), 1.47 (m, 2H, CH2CH2CH2), 2.28 (s, 3H, Me14),
2.31 (s, 3H, Me13), 6.61 (AA′ part of an AA′BB′ spin system, 2H,
H3,5), 7.03 (BB′ part of an AA′BB′ spin system, 2H, H2,6), 7.89
(m, 1H, H11), 8.13 (m, 1H, H9), 8.36 (m, 1H, H10), 8.61 (s, 1H,
H7), 8.92 (m 1H, H12). IR (KBr): ν 1615 (vw), 1594 cm-1 (m,
CdN).
Preparation of G1-pyridylimine-Pd(Cl)Me Dendritic Com-
plexes 5. Compounds 5b,c were synthesized as described above
for 2 by starting from the corresponding G1-pyridylimine dendritic
ligands G1-ONNMem (IIb,c). The preparation of 5c is reported as
an example.
G1-ONNMe2[Pd(Cl)Me] (5b). Yellow solid. Yield: 86%. Anal.
Calcd for C80H112N8O4Si5Cl4Pd4 (1957.74): C, 49.08; H, 5.77; N,
1
5.72. Found: C, 49.13; H, 5.95; N, 5.38. H NMR (CDCl3): δ
0.22 (s, 6H, SiMe2), 0.64 (m, 2H, SiCH2), 0.60 (s, 3H, PdMe),
0.81 (m, 2H, CH2SiMe2), 1.50 (m, 2H, CH2CH2CH2), 2.06 (s, 3H,
Me14), 2.21 (s, 3H, Me13), 6.58 (s, 1H, H3), 6.71 (s, 1H, H6), 7.62
(m, 1H, H11), 7.88 (m, 1H, H9), 7.99 (pt, 1H, H10), 8.42 (s, 1H,
H7), 8.97 (m, 1H, H12). 13C{1H} NMR (CDCl3): δ -0.9 (SiMe2),
0.5 (PdMe), 16.1 and 17.8 (Me13,14), 17.1 (CH2), 17.9 (CH2), 21.7
(CH2), 120.4 (C3), 124.0 (C6), 126.8 (C9), 127.1 (C5), 128.3 (C2),
128.4 (C11), 138.6 (C10), 141.0 (C1), 149.3 (C12), 151.6 (C8), 152.9.3
(C4), 167.3 (C7). IR (KBr): ν 1615 cm-1 (w), 1586 cm-1 (m, Cd
N), 1565 cm-1 (w).
[PdMe(MeCN)(Ic)]+[BArf4]- (3c). Orange-yellow solid. Yield:
93%. Anal. Calcd for C53H42N3OSiPdBF24 (1338.21): C, 47.57;
H, 3.16; N, 3.14. Found: C, 47.12; H, 3.08; N, 2.88. H NMR
1
(CDCl3): δ 0.27 (s, 9H, SiMe3), 0.79 (s, 3H, PdMe), 2.14 (s, 3H,
Me14), 2.16 (s, 3H, Me13), 2.25 (s, 3H, CH3CN), 2.53 (s, 3H, Me15),
6.63 (s, 1H, H3), 6.67 (s, 1H, H6), 7.35 (d, 1H, JH,H ) 7.8 Hz,
H11), 7.49 (broad s, 5H, H9 and Arf Hp overlapping), 7.67 (broad s,
8H, Arf Ho), 7.76 (pt, 1H, H10), 8.25 (s, 1H, H7). H NMR (CD2-
1
G1-ONNMe3[Pd(Cl)Me] (5c). [PdClMe(COD)] (59 mg, 0.22
mmol) was added to IIc (77 mg, 0.055 mmol) in dichloromethane
(15 mL), and the resulting yellow solution was stirred at room
temperature for 24 h. The solvent was removed under vacuum, and
the residue was washed with pentane (2 × 25 mL) and diethyl
ether (4 × 25 mL) to give compound 5c as an orange solid.
Analytically pure samples were obtained by operations of dissolu-
tion in CH2Cl2, filtration, and precipitation by adding pentane.
Yield: 50 mg (45%). Anal. Calcd for C84H120N8O4Si5Cl4Pd4
(2013.85): C, 50.10; H, 6.01; N, 5.56. Found: C, 49.74; H, 5.87;
Cl2): δ 0.28 (s, 9H, SiMe3), 0.81 (s, 3H, PdMe), 2.17 (s, 3H, Me14),
2.20 (s, 3H, Me13), 2.37 (s, 3H, CH3CN), 2.70 (s, 3H, Me15), 6.68
(s, 1H, H3), 6.70 (s, 1H, H6), 7.55 (broad s, 4H, Arf Hp), 7.60 (d,
1H, JH,H ) 8.0 Hz, H11), 7.66 (d, 1H, JH,H ) 7.7 Hz, H9), 7.71
(broad s, 8H, Arf Ho), 7.98 (pt, 1H, H10), 8.33 (s, 1H, H7). DEPT
experiments were useful for the assignation of 13C{1H} NMR
(CDCl3): δ 0.5 (SiMe3), 3.2 (PdMe), 8.7 (CH3CN), 16.3 and 17.7
(Me13,14), 25.1 (Me15), 117.4 (Arf Cp), 120.8 (C3), 123.7 (C6), 124.4
(q, JC,F ) 270.0 Hz, CF3), 126.0 (C9), 128.0 (C5), 128.1 (C2), 128.8
(q, JC,F ) 31.1 Hz, Arf Cm), 130.5 (C11), 134.6 (Arf Co), 139.4 (C1),-
1
N, 5.49. H NMR (CDCl3): δ 0.22 (s, 6H, SiMe2), 0.66 (m, 2H,
139.6 (C10), 150.6 (C8), 153.6 (C4), 161.4 (C12), 161.5 (q, JC,B
)
SiCH2), 0.78 (s, 3H, PdMe), 0.80 (m, 2H, CH2SiMe2), 1.50 (m,
2H, CH2CH2CH2), 2.09 (s, 3H, Me14), 2.23 (s, 3H, Me13), 3.03 (s,
3H, Me15), 6.58 (s, 1H, H3), 6.70 (s, 1H, H6), 7.42 (m, 1H, H11),
7.63 (m, 1H, H9), 7.82 (pt, 1H, H10), 8.40 (s, 1H, H7). 13C{1H}
NMR (CDCl3): δ -1.0 (SiMe2), 4.4 (PdMe), 16.2 and 17.9
(Me13,14), 17.2 (CH2), 17.9 (CH2 overlapping), 21.9 (CH2), 25.7
(Me15), 120.4 (C3), 124.2 (C6), 125.3 (C9), 127.1 (C5), 128.7 (C2),
130.1 (C11), 138.1 (C10), 141.2 (C1), 151.3 (C8), 152.8 (C4), 164.3
(C12), 168.2 (C7). IR (KBr): ν 1621 (m), 1590 cm-1 (s, CdN).
49.7 Hz, Arf Cipso), 171.0 (C7). 19F{1H} NMR (CDCl3): δ -106.3
(s, CF3). IR (KBr): ν 1611 cm-1 (m, CdN). MS (ESI+ in CH3-
CN): m/z 474 [M - BArf4]+, 312 [Ic]+. MS (ESI- in CH3CN):
m/z 863 [BArf4]-.
Preparation of G1-pyridylimine-PdCl2 Dendritic Complexes
4. Compounds 4a,b were synthesized as described above for 1 by
starting from the corresponding pyridylimine dendritic ligands G1-
ONNMem (IIa,b). The preparation of 4a is reported as an example.
G1-ONN[PdCl2] (4a). [PdCl2(COD)] (200 mg, 0.70 mmol) was
added to G1-ONN (IIa; 213 mg, 0.175 mmol) in dichloromethane
Preparation of G2-pyridylimine-Pd(Cl)Me Dendritic Com-
plexes 6. Compounds 6b,c were synthesized as described above